Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
Background: Recent evidence shows that inducing ferroptosis may improve efficacy of tumor therapy. However, ferroptosis-related genes have been little studied in patients with breast cancer especially in the neoadjuvant setting. ACSL4 and GPX4 have been well established as the positive and negative...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-09-01
|
| Series: | EBioMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421003534 |
| _version_ | 1819129551160082432 |
|---|---|
| author | Rui Sha Yaqian Xu Chenwei Yuan Xiaonan Sheng Ziping Wu Jing Peng Yaohui Wang Yanping Lin Liheng Zhou Shuguang Xu Jie Zhang Wenjin Yin Jinsong Lu |
| author_facet | Rui Sha Yaqian Xu Chenwei Yuan Xiaonan Sheng Ziping Wu Jing Peng Yaohui Wang Yanping Lin Liheng Zhou Shuguang Xu Jie Zhang Wenjin Yin Jinsong Lu |
| author_sort | Rui Sha |
| collection | DOAJ |
| description | Background: Recent evidence shows that inducing ferroptosis may improve efficacy of tumor therapy. However, ferroptosis-related genes have been little studied in patients with breast cancer especially in the neoadjuvant setting. ACSL4 and GPX4 have been well established as the positive and negative regulator of ferroptosis, respectively. This study aimed to explore the predictive value of ACSL4 and GPX4 for patients with breast cancer administered neoadjuvant chemotherapy. Methods: This study included patients treated with paclitaxel-cisplatin-based neoadjuvant chemotherapy. Immunohistochemistry staining of ACSL4 and GPX4 was carried out on the core needle biopsy specimens. Logistic regression was performed to explore the predictive biomarkers of pathological complete response (pCR). Survival analyses were examined by log-rank test and Cox proportional hazard regression. Findings: A total of 199 patients were included for the analyses. Both ACSL4 expression and ACSL4/GPX4 combination status could serve as independent predictive factors for pCR. The interaction for pCR was observed between ACSL4 and clinical tumor stage. Besides, ACSL4 expression, GPX4 expression, and their combination status were independent prognostic factors for disease-free survival. Analyses of the Kaplan-Meier Plotter database suggested that higher ACSL4 expression is related to better overall survival, and higher GPX4 expression is related to better distant metastasis-free survival. Pathway analyses revealed that ACSL4 and GPX4 might function in crucial pathways including apoptosis, autophagy, cell adhesion, lipid metabolism, etc. Interpretation: This study revealed the critical value of ACSL4 and GPX4 serving as novel predictive and prognostic biomarkers for patients with breast cancer receiving neoadjuvant chemotherapy. It might be a novel strategy to induce ferroptosis to promote chemosensitivity. Future studies are required to elucidate the potential mechanisms. Funding: This work was supported by Shanghai Natural Science Foundation [grant number 19ZR1431100], Clinical Research Plan of Shanghai Hospital Development Center [grant numbers SHDC2020CR3003A, 16CR3065B, and 12016231], Shanghai “Rising Stars of Medical Talent” Youth Development Program for Youth Medical Talents - Specialist Program [grant number 2018-15], Shanghai “Rising Stars of Medical Talent” Youth Development Program for Outstanding Youth Medical Talents [grant number 2018-16], Shanghai Collaborative Innovation Center for Translational Medicine [grant number TM201908], Multidisciplinary Cross Research Foundation of Shanghai Jiao Tong University [grant numbers YG2017QN49, ZH2018QNA42, and YG2019QNA28], Nurturing Fund of Renji Hospital [grant numbers PYMDT-002, PY2018-IIC-01, PY2018-III-15, and PYIII20-09], Science and Technology Commission of Shanghai Municipality [grant numbers 20DZ2201600 and 15JC1402700], and Shanghai Municipal Key Clinical Specialty. |
| first_indexed | 2024-12-22T08:45:31Z |
| format | Article |
| id | doaj.art-91eec8e718b8486c9e1ff2c0978537e0 |
| institution | Directory Open Access Journal |
| issn | 2352-3964 |
| language | English |
| last_indexed | 2024-12-22T08:45:31Z |
| publishDate | 2021-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EBioMedicine |
| spelling | doaj.art-91eec8e718b8486c9e1ff2c0978537e02022-12-21T18:32:08ZengElsevierEBioMedicine2352-39642021-09-0171103560Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapyRui Sha0Yaqian Xu1Chenwei Yuan2Xiaonan Sheng3Ziping Wu4Jing Peng5Yaohui Wang6Yanping Lin7Liheng Zhou8Shuguang Xu9Jie Zhang10Wenjin Yin11Jinsong Lu12Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaCorresponding authors.; Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaCorresponding authors.; Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaCorresponding authors.; Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, People's Republic of ChinaBackground: Recent evidence shows that inducing ferroptosis may improve efficacy of tumor therapy. However, ferroptosis-related genes have been little studied in patients with breast cancer especially in the neoadjuvant setting. ACSL4 and GPX4 have been well established as the positive and negative regulator of ferroptosis, respectively. This study aimed to explore the predictive value of ACSL4 and GPX4 for patients with breast cancer administered neoadjuvant chemotherapy. Methods: This study included patients treated with paclitaxel-cisplatin-based neoadjuvant chemotherapy. Immunohistochemistry staining of ACSL4 and GPX4 was carried out on the core needle biopsy specimens. Logistic regression was performed to explore the predictive biomarkers of pathological complete response (pCR). Survival analyses were examined by log-rank test and Cox proportional hazard regression. Findings: A total of 199 patients were included for the analyses. Both ACSL4 expression and ACSL4/GPX4 combination status could serve as independent predictive factors for pCR. The interaction for pCR was observed between ACSL4 and clinical tumor stage. Besides, ACSL4 expression, GPX4 expression, and their combination status were independent prognostic factors for disease-free survival. Analyses of the Kaplan-Meier Plotter database suggested that higher ACSL4 expression is related to better overall survival, and higher GPX4 expression is related to better distant metastasis-free survival. Pathway analyses revealed that ACSL4 and GPX4 might function in crucial pathways including apoptosis, autophagy, cell adhesion, lipid metabolism, etc. Interpretation: This study revealed the critical value of ACSL4 and GPX4 serving as novel predictive and prognostic biomarkers for patients with breast cancer receiving neoadjuvant chemotherapy. It might be a novel strategy to induce ferroptosis to promote chemosensitivity. Future studies are required to elucidate the potential mechanisms. Funding: This work was supported by Shanghai Natural Science Foundation [grant number 19ZR1431100], Clinical Research Plan of Shanghai Hospital Development Center [grant numbers SHDC2020CR3003A, 16CR3065B, and 12016231], Shanghai “Rising Stars of Medical Talent” Youth Development Program for Youth Medical Talents - Specialist Program [grant number 2018-15], Shanghai “Rising Stars of Medical Talent” Youth Development Program for Outstanding Youth Medical Talents [grant number 2018-16], Shanghai Collaborative Innovation Center for Translational Medicine [grant number TM201908], Multidisciplinary Cross Research Foundation of Shanghai Jiao Tong University [grant numbers YG2017QN49, ZH2018QNA42, and YG2019QNA28], Nurturing Fund of Renji Hospital [grant numbers PYMDT-002, PY2018-IIC-01, PY2018-III-15, and PYIII20-09], Science and Technology Commission of Shanghai Municipality [grant numbers 20DZ2201600 and 15JC1402700], and Shanghai Municipal Key Clinical Specialty.http://www.sciencedirect.com/science/article/pii/S2352396421003534Breast cancerNeoadjuvant chemotherapyPathological complete responseFerroptosisACSL4GPX4 |
| spellingShingle | Rui Sha Yaqian Xu Chenwei Yuan Xiaonan Sheng Ziping Wu Jing Peng Yaohui Wang Yanping Lin Liheng Zhou Shuguang Xu Jie Zhang Wenjin Yin Jinsong Lu Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy EBioMedicine Breast cancer Neoadjuvant chemotherapy Pathological complete response Ferroptosis ACSL4 GPX4 |
| title | Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy |
| title_full | Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy |
| title_fullStr | Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy |
| title_full_unstemmed | Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy |
| title_short | Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy |
| title_sort | predictive and prognostic impact of ferroptosis related genes acsl4 and gpx4 on breast cancer treated with neoadjuvant chemotherapy |
| topic | Breast cancer Neoadjuvant chemotherapy Pathological complete response Ferroptosis ACSL4 GPX4 |
| url | http://www.sciencedirect.com/science/article/pii/S2352396421003534 |
| work_keys_str_mv | AT ruisha predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT yaqianxu predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT chenweiyuan predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT xiaonansheng predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT zipingwu predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT jingpeng predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT yaohuiwang predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT yanpinglin predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT lihengzhou predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT shuguangxu predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT jiezhang predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT wenjinyin predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy AT jinsonglu predictiveandprognosticimpactofferroptosisrelatedgenesacsl4andgpx4onbreastcancertreatedwithneoadjuvantchemotherapy |